Discover Great Companies Discover Great Clients
Popularity  11.5万   |   Followers  28   |   Likes  28   |   Feedback  8 Claim this company

A renowned enterprise in China's liver disease and anti-tumor fields

No.2 Lianyungang City Popularity Ranking No.2 Lianyun District No.15 Jiangsu Pr No.1 Gong Cheng Yan Jiu Center No.1 Sheng Wu Ke Ji / Biotechnology Engineering No.2 Zhi Yao / Yao Industries No.2 Pharmaceutical Technology No.2 Biopharmaceuticals No.2 Lin Chuang Yi Xue No.2 Pharmaceutical Industrial No.2 Pharmaceutical Yi Yao Jing Ji Kang Bing Du Yao Products Sheng Ming Ke Xue Biological Products 企业技术中心 博士后工作站 国家高新技术企业 国药准字 副会长单位 高新技术企业 FDA认证
More

Company Overview

  • Nature: Joint Venture Size: Over 10,000 employee Founded: 29年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.。

Development Stage

  • Ranking: Ranked #2 in Lianyungang City by popularity Ranked #1 in Lianyungang Gong Cheng Yan Jiu Center Company by popularity Ranked #1 in Lianyungang Sheng Wu Ke Ji / Biotechnology Engineering Company by popularity Ranked #2 in Lianyungang Zhi Yao / Yao Industries Company by popularity Ranked #2 in Lianyungang Pharmaceutical Technology Company by popularity
  • Honors: 2025中国制造业500强 2025中国专利实力500强 企业技术中心 博士后工作站 According to algorithm
  • News: 2026-05-11:中国生物制药:正大天晴与葛兰素史克达成一项独家战略合作。
  • Salary: 71.6% of positions earn 10-20K, In 2026 vs last yeardecreased by 8%.。Master's salary: ¥23.3K, Doctorate salary: ¥30.8K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 36%, "Computer/Network/Technology": 10.5%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 9.3%。
  • Recruiting: In 2026 vs 2025grew by 79%. Demand for highly educated talent: Master's: 264, Doctorate: 32.
  • Requirement: Education: 本科 leads with 68%. Experience: 1-3年 leads with 64.8%.
  • Region: Distributed across 100 regions, 南京: 21.8%, 上海: 6.5%, 连云港: 4.5%, 北京: 3.5%.

About the Company

[Summary] A renowned enterprise in China's liver disease and anti-tumor fields

Chia Tai Tianqing Pharmaceutical Group is an innovative pharmaceutical group engaged in the R&D, production, and sales of pharmaceutical innovations and high-quality drugs. As a core enterprise of Sino Biopharmaceutical Limited (01177.HK), a Hong Kong-listed company, it is committed to providing patients with better health solutions and high-quality, affordable pharmaceutical resources. It is a nationally renowned R&D and production base for anti-tumor, liver disease, and respiratory drugs, recognized as a key national high-tech enterprise, a key backbone enterprise of the National Torch Plan Lianyungang New Medicine Industry Base, ranked 9th on the Top 100 Chinese Pharmaceutical Industry Enterprises list, and named the best industrial enterprise for pharmaceutical R&D product lines in China.

Chia Tai Tianqing has always regarded technological innovation as a pillar for sustainable development, with R&D investment accounting for approximately 20% of sales revenue in 2025, of which over 85% is allocated to innovative drug development. Leveraging its research institutes as innovation carriers, the company has successively established high-level R&D platforms such as the National Enterprise Technology Center, the National Postdoctoral Research Station, the Jiangsu Provincial Key Laboratory of Antiviral Drug Research, the Jiangsu Provincial Engineering Technology Research Center for New Liver Disease Drugs, the Jiangsu Provincial Engineering Technology Research Center for Crystal Form Drugs, and the Jiangsu Provincial Engineering Technology Research Center for Innovative Biological Products, continuously enhancing its R&D and innovation capabilities. Currently, the company has over 130 projects under development, including more than 100 innovative drugs, has undertaken 33 national major special projects, accumulated over 3,700 effective applications and patents, and holds more than 1,400 valid authorized patents, forming a sound pattern of "launching one generation, reserving one generation, and developing one generation."

Chia Tai Tianqing has established 5 major R&D and production bases in Nanjing, Lianyungang (Jiangsu Province), and Shanghai. Its formulation base obtained the first new version GMP certificate in China, and multiple production lines have passed EU cGMP and US FDA certifications, indicating that the company's drug production quality and management standards are at the forefront of the national pharmaceutical industry.

Guided by unmet clinical needs and supported by outstanding R&D innovation and manufacturing capabilities, Chia Tai Tianqing focuses on building product clusters in oncology, liver diseases, and respiratory diseases. In the liver disease field, the Class 1 innovative drug Magnesium Isoglycyrrhizinate Injection (Tianqing Ganmei®) won the 10th China Patent Gold Award; in the oncology field, the Class 1 innovative drug Anlotinib (Fukewei®) won the 23rd China Patent Award and set a record for Chinese innovative drugs selected for oral presentations at the 2025 ASCO conference. From 2024 to 2025, with the market launch of five Class 1 innovative drugs—Anlotinib Hydrochloride Capsules (Anbekit®)...

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Chia Tai Tianqing How Fast Is Hiring Growing? (1640 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 27%
  • 2024: Down 22%
  • 2023: Up 52%
Chia Tai Tianqing Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Chia Tai Tianqing Campus Recruitment & Advanced Degree Talent Demand
Graduates 129 Interns 10 Master's 264 Doctorate 32
No.6
Company Recruitment Ranking in Lianyungang City 򀀩
No.18
Recruitment Growth Ranking in Lianyungang City 򀀩
No.2
Graduate Talent Ranking in Lianyungang City 򀀩
No.4
Intern Talent Ranking in Lianyungang City 򀀩
Note: How fast is hiring at Chia Tai Tianqing Pharmaceutical Group Co., Ltd. growing? Chia Tai Tianqing2026: 3496 openings (up 79%), 2025: 1956 openings (up 27%), 2024: 1535 openings (down 22%), 2023: 1970 openings (up 52%), 2022: 1293 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Chia Tai Tianqing Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 44%
  • 2024: Down 29%
  • 2023: Up 40%
Chia Tai Tianqing Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Chia Tai Tianqing Pharmaceutical Group Co., Ltd. growing? Chia Tai TianqingMaster's recruitment over the years: 2025: 228 openings (up 44%), 2024: 158 openings (down 29%), 2023: 223 openings (up 40%), 2022: 159 openings. Chia Tai Tianqing master talent ranking in Lianyungang: #2, Chia Tai Tianqing master salary mostly around 10-30K.

Chia Tai Tianqing Doctoral Degree Job Demand Analysis

(More)
+152%
Growth Rate
2026 vs 2025
  • 2025: Up 425%
  • 2024: Down 56%
  • 2023: Down 40%
Chia Tai Tianqing Doctoral Hiring by Year: 2026 — 32 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Chia Tai Tianqing Pharmaceutical Group Co., Ltd. growing? Chia Tai TianqingDoctorate recruitment over the years: 2026: 53 openings (up 152%), 2025: 21 openings (up 425%), 2024: 4 openings (down 56%), 2023: 9 openings (down 40%), 2022: 15 openings. Chia Tai Tianqing doctorate talent ranking in Lianyungang: #2, Chia Tai Tianqing doctorate salary mostly around 20-50K.

Chia Tai Tianqing R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Chia Tai Tianqing Pharmaceutical Group Co., Ltd.? Based on an analysis of Chia Tai Tianqing's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 36%, "Computer/Network/Technology": 10.5%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 9.3%, "Other (R&D and Technical)": 5.4%, "Scientific Research": 4.3%, "Mechanical/Instrumentation": 0.9%. For reference only.

Chia Tai Tianqing — What Are the Salaries Like? (3128 records)

Manage
salary range: 4.5K - 50K, 71.6% of roles pay ¥10-20K
Note: salary statistics are based on 3128 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Chia Tai Tianqing Pharmaceutical Group Co., Ltd.?Chia Tai Tianqing71.6% of positions earn 10-20K, Fresh graduate salary: ¥7.8K。Lianyungang salary ranking top 15,Sales average salary ¥14.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Chia Tai Tianqing

(More)
Are salaries high at Chia Tai Tianqing Pharmaceutical Group Co., Ltd.? We provide: Pharmaceutical Sales Representative, Product Manager, Promotion Specialist, 临床, Researcher, Academic Specialist, Medical Science Liaison, Analyst, Marketing, Retail, 药学, BP, Sales, Verification Engineer, Medical Manager, Project Manager, Key Account Manager, Division Manager, QA, Product Specialist. Click to view detailed salary analysis by job.

Chia Tai Tianqing — Fortune 500? (More)

Yes, ranked in 中国制造业500强:

  • NO.419 2025中国制造业500强 >
  • NO.422 2024中国制造业500强 >
  • NO.410 2023中国制造业500强 >

Yes, ranked in 中国专利实力500强:

  • NO.193 2025中国专利实力500强 >
  • NO.214 2023中国专利实力500强 >
  • NO.180 2022中国专利实力500强 >

Job Category

  • Sales
    44.1% of total 44.1%
  • Medical & Health/Beauty & Healthcare
    35% of total 35%
  • Administration/Logistics
    15.2% of total 15.2%
  • Marketing/PR/Media
    12.3% of total 12.3%

Education

  • 本科
    68% of total 68%
  • 硕士
    14.8% of total 14.8%
  • 不限
    13.3% of total 13.3%
  • 大专
    2.4% of total 2.4%

Experience

  • 1-3年
    64.8% of total 64.8%
  • 不限
    12% of total 12%
  • 3-5年
    11.1% of total 11.1%
  • 5-10年
    8.2% of total 8.2%
View Detailed Analysis

What does Chia Tai Tianqing Pharmaceutical Group Co., Ltd. require? Who is Chia Tai Tianqing hiring? Chia Tai Tianqing recruitment: Sales占比最多占44.1%,其次是Medical & Health/Beauty & Healthcare占35%. What education can get in at Chia Tai Tianqing? 本科占比最多占68%,其次是硕士占14.8%. High education required at Chia Tai Tianqing? 硕士占14.8%,博士占1.4%. Work experience required at Chia Tai Tianqing? 1-3年占比最多占64.8%,其次是不限占12%. Where are the job locations at Chia Tai Tianqing? 南京占比最多占21.8%,其次是上海占6.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 89,000万(元)
Legal Representative: 陈辉
Date Established:
Credit Code: 91320000608398264T
Registered Address: 江苏省连云港市郁州南路369号

Partners & Suppliers

委托益诺思进行非临床安全性评价服务 Source
供应商 非临床CRO服务-客户
宣城美诺华向正大天晴供应原料药。 Source
供应商 原料药客户-国内制药
正大天晴药业集团股份有限公司为江苏润天医药连锁药房有限公司提供化学药品的采购供应 Source
合作客户 化学药
正大天晴为重药控股吉林有限公司提供肝病及抗肿瘤药品 Source
合作客户 药品生产
提供一次性储液袋、取样袋等 Source
供应商 生物工艺一次性耗材

People who follow Chia Tai Tianqing also follow

Chia Tai Tianqing Competitors (Similar Companies)

“Research, development, and production of anti-tumor and surgical medic”
“Health for Humanity, Creating a Better Future Together”
“Seek and strive, protect and heal all beings”
“To develop high-quality biologics that are accessible and affordable f”
“Continuously innovating to bring patients medicines that significantly”
“A large traditional Chinese medicine enterprise integrating R&D, produ”
“Mainly engaged in the production and sales of antibiotics, traditional”
“Professional services for the entire clinical trial process of drug pr”
“Caring for life, safeguarding health”
“Helping patients access more effective medicines sooner”
“Leading enterprise in the field of central nervous system drugs in Chi”
“One of the leading enterprises in the pharmaceutical industry”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“Providing first-class solutions for global new energy applications”
“Caring for Public Health, Creating a Better Life Together”

Discover Great Companies, Discover Great Clients

连云港公司名录 连云港“Lianyun District”公司名录 连云港“制药/药业”公司名录 连云港“医药工业”公司名录 连云港“医药”公司名录 连云港“生物科技/生物工程”公司名录 连云港“医药科技”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates